Drugs.com - New Drug Approvals

FDA Approves HemiClor (chlorthalidone) for the Treatment of Hypertension

West Conshohocken, PA—April 16, 2025—PRM Pharma, LLC today announced the U.S. Food and Drug Administration (FDA) approval of HemiClor (12.5 mg chlorthalidone) tablets for the treatment of hypertension in adults, to lower blood...

May 7, 2025 - 01:00
 0
FDA Approves HemiClor (chlorthalidone) for the Treatment of Hypertension
West Conshohocken, PA—April 16, 2025—PRM Pharma, LLC today announced the U.S. Food and Drug Administration (FDA) approval of HemiClor (12.5 mg chlorthalidone) tablets for the treatment of hypertension in adults, to lower blood...
Read More

Tags:

Previous Article

Trump adds another 10 FAST-41 projects

Next Article

Obtaining Second Opinion Delays Treatment for Breast Cancer, but Not Appreciably

Related Posts

U.S. Food and Drug Administration Updates Camzyos (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications

U.S. Food and Drug Administration Updates Camzyos (mava...

Apr 22, 2025  0

Alnylam Announces FDA Approval of Amvuttra (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Death, Hospitalizations and Urgent Heart Failure Visits in Adults with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM)

Alnylam Announces FDA Approval of Amvuttra (vutrisiran)...

Apr 26, 2025  0

Tevimbra Approved in U.S. for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma in Combination with Chemotherapy

Tevimbra Approved in U.S. for First-line Treatment of A...

Apr 26, 2025  0